All posts by imreal

BrightStar Care Founder and CEO Shelly Sun Receives McKnight’s Women of Distinction Award


News Image

BrightStar Care, Founder, and CEO Shelly Sun was named a McKnight’s Women of Distinction award winner in the Hall of Honor category for 2023. McKnight’s prestigious Women of Distinction awards is a joint program of McKnight’s Long-Term Care News, McKnight’s Senior Living, and McKnight’s Home Care. The program, in its fifth year, recognizes women who have made a significant impact on their organization or in the industry.

This spring, Sun will be inducted into the Hall of Honor as part of McKnight’s Women of Distinction awards program which honors senior-level professionals in the C-suite or at a level equivalent to the vice president or higher who have made instrumental contributions to their organizations and have established innovation and growth within their companies. McKnight’s also considers each winner’s exceptional achievements and commitment to service including their charitable endeavors, academic accomplishments, and influence on the industry.

“I am immensely grateful to be recognized on McKnight’s reputable 2023 Women of Distinction list and to be named among other fierce, innovative women in the healthcare space,” said Shelly Sun, Founder and CEO of BrightStar Care. “Since launching BrightStar Care more than 20 years ago my goal has been to enrich lives and provide the full continuum of care, which has been validated by my network’s superior clinical outcomes and Joint Commission Accreditation. I am passionate about empowering the next generation of entrepreneurs, franchisees, and healthcare executives, and am thrilled that my leadership as a female founder is being recognized at this national level.”

Nominations for this distinguished honor were judged by an external panel of industry experts. Twenty-one elite executives in skilled nursing, senior living, and home care are being inducted into McKnight’s Women of Distinction Hall of Honor this year. All winners will be honored at an in-person celebration on May 22 in Chicago hosted by McKnight’s.

To see the full list of inductees, and for more information about the program and Sun’s distinct honor visit http://www.mcknightswomenofdistinction.com. For more information on BrightStar Care and Founder and CEO Shelly Sun, please visit http://www.brightstarcare.com.

About BrightStar Care:

Founded in 2002, BrightStar Care is a national home care agency with more than 370 corporate-owned and franchised locations nationwide that provide medical and non-medical home health care services to clients and supplemental care staff to businesses. BrightStar Care corporate and franchise agencies across the country employ more than 15,000 caregivers and 5,700 registered nurses who oversee the care and safety of each individual client. BrightStar Care offers custom medical staffing solutions to corporate entities and holds national accounts with government agencies across distinct patient populations providing healthcare staff anywhere care is needed. Female founded and led by CEO Shelly Sun, BrightStar Care is committed to providing a higher standard of care through its clinical nurse-led care model. As a member of Moving Health Home, BrightStar Care also actively advocates to change federal and state policies that prevent the home from being an accredited clinical care site. Network-wide BrightStar Care agencies are Joint Commission accredited – the gold standard within the health care industry. BrightStar Care has also been the only national home care franchise to consecutively receive The Joint Commission’s Enterprise Champion for Quality award for more than a decade.

Share article on social media or email:

American Parkinson Disease Association (APDA) to Celebrate the Importance of Community & Connection During Parkinson’s Disease Awareness Month


APDA logo and tagline

“In April alone nearly 7,200 people in this country will learn they have Parkinson’s disease. These people need to know that they are not alone, and that APDA is here for them” — Leslie A. Chambers, President and CEO

April is Parkinson’s Disease Awareness Month and the American Parkinson Disease Association (APDA) is hard at work to raise awareness of Parkinson’s disease (PD) and to celebrate the important connections that help foster a supportive community for people impacted by PD. Through a nationwide network of Chapters and Information & Referral (I&R) Centers, APDA works tirelessly to provide the support, education and research that helps people impacted by PD live life to the fullest. Often the first line of defense after a diagnosis, APDA connects people to the information they need to feel more in control; to the medical experts who can help them manage their disease; and to the support and services that can help them feel less alone throughout their PD journey.

APDA Chapters and I&R Centers have a full roster of activities planned for the month (and beyond) and many ways for people to get involved. Throughout April, APDA will share educational information, along with messages of inspiration and connection on all APDA social media channels using #APDAconnects.

There are 90,000 new diagnoses of Parkinson’s disease every year. Now more than ever, it is critical to support, engage, and inform the PD community and raise awareness about this disease, and Parkinson’s Disease Awareness Month is a great time to shine a spotlight on this issue.

“Every six minutes there is a new diagnosis of PD, which means that in April alone nearly 7,200 people in this country will learn they have PD. These people need to know that they are not alone, and that APDA is here for them” states Leslie A. Chambers, President and CEO, APDA.

“We are the boots on the ground, building local PD communities that lift each other up – from support groups and exercise classes to educational seminars and financial support programs – APDA can help connect you to so many people and resources that can make your PD experience more positive” Chambers continues.

In addition to the local in-person events taking place, APDA offers extensive virtual programming to make sure that no matter where you live, you have access to high-quality PD information and programs and feel connected to the PD community even from afar. From the popular Dr. Gilbert Hosts webinar series and the ongoing Spanish-language Café con la doctora program, to the robust calendar of virtual exercise and movement classes– there is something for everyone.

The support of the general public is crucial, and April is the perfect time to take action and help the more than one million people in the United States coping with this chronic neurological movement disorder. Whether you help by raising awareness of PD or by making a donation that enables APDA to continue their critical work and fund research that will lead us to better treatments and ultimately, a cure; every effort makes a difference. Visit http://www.apdaparkinson.org to learn more.

About the American Parkinson Disease Association:

The American Parkinson Disease Association (APDA) is the largest grassroots network dedicated to fighting Parkinson’s disease (PD) and works tirelessly to help the more than one million people in the U.S. with PD live life to the fullest in the face of this chronic, neurological disorder. Founded in 1961, APDA has raised and invested more than $226 million to provide outstanding patient services and educational programs, elevate public awareness about the disease, and support research designed to unlock the mysteries of PD and ultimately put an end to this disease. To join us in the fight against Parkinson’s disease and to learn more about the support APDA provides nationally through our network of Chapters and Information & Referral (I&R) Centers, as well as our national Research Program and Centers for Advanced Research, please visit us at http://www.apdaparkinson.org.

# # #

Share article on social media or email:

CS Analytical Hosting Educational Webinar on USP 661.1 and USP 661.2


USP 661.1 and 661.2 Testing of Plastic Materials, Components, and Systems

The goal of this webinar is to provide key industry stakeholders with an overview of 661.1 and 661.2 applicability, a historical review of changes to-date, a discussion of current challenges in implementing the new methods, and modern testing approaches to help ensure compliance

CS Analytical Laboratory, the world’s only FDA regulated contract laboratory exclusively dedicated to providing regulatory solutions and qualification testing services specifically for drug product and medical device container systems, is excited to announce that it will be hosting an educational webinar on USP General Chapters 661.1 and 661.2, which will become effective on December 1, 2025. The webinar is scheduled for Wednesday April 19, 2023 at 10:00am through 11:30am ET and will cover all pending and current testing requirements and a key discussion on pending changes that are under consideration. This webinar will be hosted by Brandon Zurawlow, Chief Scientific Officer for CS Analytical. The webinar is free of charge and attendees may register at this link: https://engage.csanalytical.com/webinar

“Over the past decade, the USP 661 chapter has undergone a series of revisions that have made the development and implementation of a testing strategy much more complex. Understanding these changes is paramount to ensuring that your container and package systems meet these new requirements that will become effective December 1, 2025,” noted Brandon Zurawlow, CSO. “The goal of this webinar is to provide key industry stakeholders with an overview of 661.1 and 661.2 applicability, a historical review of changes to-date, a discussion of current challenges in implementing the new methods, and modern testing approaches to help ensure compliance.”

USP 661.1 is designed to characterize plastic materials used in the construction of a packaging component or system, whereas USP 661.2 chapter is intended to be applied to plastic packaging systems. While portions of these chapters may continue to evolve, with 661.2 back in USP PF for industry review, there is no expectation that there will be any additional delay to the December, 2025 effective date. With the date for required compliance rapidly approaching, now is the time for companies to begin planning the most efficient and effective strategy to meet the new and more comprehensive test requirements. Webinar attendees will gain valuable insight into how to consider and address critical issues for USP 661.1 and USP 661.2 testing.

About CS Analytical Laboratory

The only FDA regulated, cGMP laboratory dedicated exclusively to the complex world of drug and medical device container and package qualification testing, the CS Analytical Team includes the world’s leading experts on all relevant USP and EP requirements and the thought leaders and pioneers on CCI (container closure integrity – CCI) testing. Offering a full suite of laboratory services to include all USP, EP and JP procedures specific to glass, plastic, and elastomers, as well as complete USP 1207 services that span basic feasibility studies, component qualification programs and advanced method development and validation for helium leak testing, vacuum decay, high voltage and headspace analysis leak testing. CS Analytical is the one source that can ensure your medical product container and package system meets the strict and complex regulatory requirements.

Share article on social media or email:

InSpan granted patent protection by the US Patent Office for its unique interspinous technique and instruments designed for treating spinal stenosis and fusion in the ASC


InSpan’s Patent For Its Percutaneous Mini-Open Interspinous-Interlaminar Outpatient Technique and Instruments For Spinal Stenosis and Spinal Fusion

“I am seeing excellent clinical results of using InSpan for treating spinal stenosis and for spinal fusions in many of my patients,” said board-certified orthopedic spine surgeon Dr Erik Spayde.

NANISX LLC is the parent company for InSpan LLC and is grateful that the US Patent Office (USPTO) has allowed for issuance as a patent to protect the unique InSpan approach. This is yet another momentous achievement and a leap forward for patients with spine pain, especially over 55 years old, who want a safe and less invasive surgery with quick recovery in an outpatient ambulatory surgery center (ASC).

InSpan has been FDA-cleared since 2010 and thousands have been implanted safely with excellent clinical outcomes and no adverse device related events. A recent peer-reviewed publication on InSpan in the Journal of Spine Surgery (JSS) described the clinical results of Inspan being used to treat spinal stenosis at L4-5 with greater than five-year follow-up demonstrates the proof for its effectiveness. On November 24, 2021, InSpan had another groundbreaking Achievement, as the FIRST Interspinous-interlaminar Plate Fixation Device (IPD) granted the dual FDA approval for spinal fusion and spinal stenosis from T1-S1 in selected patients.

“This new InSpan patent makes the procedure simple, adjustable, fast and effective (SAFE) and minimal blood loss,” said Dr Kingsley R Chin, professor and board-certified orthopedic spine surgeon.

“We made the financial investment to improve the technology to build InSpan as the leading interspinous-interlaminar fixation device,” said Vito Lore, Chief Technology Officer. “We continue to make strategic and timely investments to increase value in our portfolio” said Aditya Humad, CFO of KIC Ventures.

“We are seeing excellent clinical results of using InSpan for treating spinal stenosis and for spinal fusions in many of our patients,” said board-certified Orthopedic spine surgeons Dr Erik Spayde and Dr. William Costigan. “We have used InSpan to treat over 790 patients, mostly as supplemental fixation to anterior and lateral lumbar interbody fusions,” said Dr Joseph Aferzon a neurosurgeon. Dr Luis Fandos, a leading board-certified anesthesia pain management physician said, “I have tremendous success using InSpan in patients who failed decompression or to revise prior surgeries with a competing interspinous spacer, which led me to recommend InSpan as a reliable and strong fixation solution.”

Visit InSpan to request help in locating a doctor near you that performs InSpan surgeries.

About InSpan, LLC

InSpan LLC is under the NANISX LLC umbrella with Sacrix LLC and NanoFuse Biologics LLC, 100% privately owned by the KIC Ventures healthcare investment holding company.

https://www.MyInspan.com/

About KIC Ventures

Our founders have been investing in spine surgery since 2000, which makes us the most experienced healthcare investment holding company with the largest portfolio of medical device technologies focused on solutions for less invasive outpatient spine surgery.

https://www.KICVentures.com/

Investors

Contact us using the contact form.

INVESTOR@kicventures.com.

Share article on social media or email:

Joseph Simone Says That Housing Is Critical For New Life Science Sites


Joe Simone, President, Simone Development Companies

“Life science and healthcare executives have clearly linked the availability of quality workforce housing to their growth,” said Joanna Simone, Principal and President of Leasing and Property Management Operations at Simone Development Companies.

New life science campuses are incorporating more housing to satisfy knowledge workers’ demand for live, work, play communities, said Joseph Simone of Simone Development Companies.

“Life scientists and tech workers increasingly expect communities where walking or biking to work are viable options. These employee preferences are leading developers of mixed-use healthcare and life science projects to incorporate more workforce housing into their plans,” said Joe Simone, President of Simone Development Companies.

The latest example of this mix is New York developer RXR’s plan for a $3 billion community in North Carolina’s Research Triangle. RXR has proposed building 750,000 square feet for life-science research, logistics and education. A housing component includes 1,100 single-family homes and 1,000 rental apartments.

RXR called the development site in Apex, N.C., a “superstar region” with strong education and healthcare systems that are magnets for knowledge workers in search of a superior quality of life. Access to housing is essential for the growing health tech sectors nationwide. At the March 7 Life Sciences Forum in Worcester, Mass., the president of Lykan Bioscience said that his region’s high housing costs hindered his company’s growth and recruitment.

In the Bronx, Simone Development Companies’ Hutchinson Metro Center is a 42-acre, mixed-use campus planning a 33-acre expansion that may include life science labs, medical offices, housing, and destination retail. Around the Hutchinson Metro Center, New York City’s planners envision up to 6,000 new housing units to support the growth of employers in this job center populated by hospitals, the Albert Einstein College of Medicine and affiliated healthcare businesses.

“Life science and healthcare executives have clearly linked the availability of quality workforce housing to their growth. Simone Development Companies is studying the feasibility of workforce housing opportunities for our Hutchinson Metro Center expansion to enhance our future tenants’ recruitment efforts,” said Joanna Simone, Principal and President of Leasing and Property Management Operations at Simone Development Companies.

Simone Development Companies is a full-service real estate investment company specializing in the acquisition and development of healthcare, mixed-use, office, industrial, retail, and residential properties. Headquartered at the Hutchinson Metro Center, it boasts a portfolio of over 7 million square feet throughout the Bronx, Manhattan, Queens, Long Island, Westchester County, Orange and Fairfield Counties and New Jersey. With services spanning acquisition, development, construction, finance, asset management, accounting, leasing and property management, Simone Development Companies is set apart by its vertically integrated management team, long-term asset ownership and its pursuit of visionary development.

Share article on social media or email:

BayMark Opens New Opioid Treatment Program In Cuyahoga County, Ohio


BayMark Logo with waves

“Fentanyl was present in more than 80% of overdose deaths in Ohio in 2020 and is now the leading cause of drug overdose in Cuyahoga County… We are committed to providing accessible, effective and affordable care to the communities that need it most.”

BayMark Health Services announced the opening of their newest MedMark Treatment Centers clinic in Parma Heights, Ohio, conveniently located approximately 10 miles southwest of Cleveland. MedMark Parma Heights provides evidence-based treatment, including medication, counseling and supportive recovery services, for adults living with an opioid use disorder. The new location at 6700 Pearl Road in Parma Heights is now accepting new and transferring patients.

“The opioid epidemic has been a critical issue in Ohio for more than a decade, but in recent years has been exacerbated by the appearance and widespread use of the deadly drug fentanyl,” shared David K. White, Ph.D., CEO of BayMark Health Services. “Fentanyl was present in more than 80% of overdose deaths in Ohio in 2020 and is now the leading cause of drug overdose in Cuyahoga County. That made it very clear where our services were most needed as we continue our expansion across Ohio. We are committed to providing accessible, effective and affordable care to the communities that need it most.”

MedMark Treatment Centers are known across the country as providers of comprehensive, individualized treatment for opioid use disorder. Through medication management and counseling, medication-assisted treatment (MAT) reduces the symptoms of withdrawal and cravings, paving the way for patients to focus on addressing the causes and consequences of their addiction and developing new tools and resources to regain stability in their lives. Additionally, MedMark Parma Heights will provide addiction education, relapse prevention, lab testing, coordinated care for pregnant patients and linkages to community resources in a brand-new facility following all current CDC guidelines for health and safety. For more information on MedMark and our services visit: http://www.MedMark.com.

To inquire about admission or make a referral, contact Adriann Winn, Treatment Center Director, at 440-941-1933.

About BayMark Health Services:

BayMark Health Services provides Substance Use Disorder (SUD) treatment over 70,000 patients in recovery across more than 400 treatment facilities in 37 states and 3 Canadian provinces. The largest provider of Opioid Use Disorder (OUD) services in North America and the leader in evidence-based treatment options for SUD’s, BayMark’s continuum of care includes medication-assisted treatment (MAT), withdrawal management, PHP, IOP, counseling and other innovative support therapies in outpatient, inpatient and residential settings.

Share article on social media or email:

The Bair Foundation Partners With the State of Virginia To Help Foster Children Who Have Waited Over a Year To Leave Residential Placements, Group or Foster Homes


The state has identified 20–30 children who are in treatment facilities, group homes or in foster homes unable to support them, who will need foster families trained by The Bair Foundation to support their healing and transition planning.

The Bair Foundation is one of three select agencies chosen to partner with the state of Virginia to help foster children during a transition from residential treatment facilities. Professional Treatment Foster Care (PTFC) is a specialized form of foster care that is designed to meet the unique needs of children with significant emotional, behavioral, medical, and mental health needs.

In June 2022, the state of Virginia added $1.1 million to create an enhanced treatment foster care pilot program to support foster homes caring for high acuity children. In addition to enhanced programming and training, families will receive an annual stipend of $45,000. The state has identified 20–30 children who are in treatment facilities, group homes or in foster homes unable to support them, who will need foster families trained by The Bair Foundation to support their healing and transition planning.

The added support for parents will include specialized training and weekly therapeutic support to meet the child’s individual needs. Families will have dedicated therapists and caseworkers for critical support, in addition to specialized training provided by The Bair Foundation.

“As more children with intense behavioral, mental and special needs linger in the system, finding foster families who are equipped to support these children is getting harder,” said Dr. Susan Miklos, Executive Director of The Bair Foundation. The goal of treatment foster care is to help the child heal and grow and ultimately return to their family or a permanent home.

The Bair Foundation has over 50 years of providing quality foster care services and is committed to meeting the needs of children and families.

Press Contacts:

  • Lynchburg: 300 Gristmill Drive, Unit C, Forest, VA 24551 Director: David Helfrich, Phone: 434-425-7157, dhelfrich@bair.org
  • Richmond: 2727 Enterprise Parkway, Suite 102, Richmond, VA 23294, Director: Adrienne Jones Phone: 804-288-8210, ajones@bair.org
  • Virginia Beach: 184 Business Park Drive, Suite 200, Virginia Beach, VA 23462 Director: Jennifer Gilliam, Phone: 757-424-2861, jgilliam@bair.org

Share article on social media or email:

Spring is in Full Bloom with Viori’s Newest Limited-Time Offer Lavender Shampoo and Conditioner Bars


News Image

Our Purple Lavender shampoo and conditioner bars are not only great for hair, they’re also beautiful and our fans have been raving about them

Viori™, an all-natural hair cosmetics brand is excited to offer this limited- quantity and limited-time product. Click here to learn about its new Lavender Purple Bars which are only available until the end of March 2023.

Lavender has long been lauded for its positive effects on mood and its anti-inflammatory effects. Now it’s being combined with the same Longsheng Rice and natural ingredients used by the Red Yao of Longsheng, China for centuries. Viori shampoo and conditioner bars are sulfate-free, paraben-free, phthalates-free, pH balanced, natural, 100% vegan, plastic-free, sustainable, cruelty-free, and ethically sourced.

Viori’s Lavender Purple Bar, a luxurious hair cleansing and conditioning bar, will leave consumers feeling refreshed and rejuvenated. Infused with the delicate scent of freshly picked lavender, this bar lathers up to provide a gentle yet invigorating hair care experience. The subtle purple hue of the bar is derived through the use of natural sweet potato powder, a testament to Viori’s commitment to using only the finest natural ingredients. The Lavender Purple Bar is formulated with a nourishing blend of natural oils and butters that work together to cleanse, condition, and strengthen hair, leaving it soft, smooth, and radiant.

“Our Purple Lavender shampoo and conditioner bars are not only great for hair, they’re also beautiful and our fans have been raving about them,” said Tszman Fisher, co-founder of Viori. “Lavender is the most popular essential oil scent in the world so it’s no surprise our customers are excited by this limited time offer, we’re confident this will sell out quickly.”

Lavender Purple Shampoo + Conditioner Bars are good for all hair types and gentle enough for daily use.

Viori Products

Shampoo and Conditioner Bars Viori™ shampoo and conditioner bars are sulfate-free, paraben-free, phthalates-free, pH balanced, natural, 100% vegan, plastic-free, sustainable, cruelty-free, and ethically sourced.

Sunrise Mist Dry Shampoo This fast-absorbing dry shampoo nourishes hair, neutralizes odor and leaves no residue. Its light cocoa, vanilla scent is 100% natural and is talc-free. It’s 100% natural, vegan, sulfate-free, paraben-free, cruelty-free and plastic-free.

Body wash Bars Viori™ body wash bars cleanse and moisturize the skin. They’re 100% natural, vegan, sulfate-free, paraben-free, cruelty-free, and plastic-free. Available in natural aloe scent or unscented.

Handcrafted Bamboo Comb Made by a guild of bamboo artisans who have been nurturing their local bamboo and perfecting their craft for centuries. Bamboo gently massages the scalp and detangles hair, promoting circulation and distributing natural oils to increase shine.

Bamboo bar holders. Handcrafted by local villagers in southern China. These bamboo bar holders are eco-friendly, biodegradable, and 100% sustainable. You can also stack these holders in order to save space in the shower.

Digital Gift Cards Not sure what to buy? A gift card lets the recipient choose whatever they want.

To order Viori products visit https://viori.com/

About Viori™

All Viori™ products contain the same, ritually prepared Longsheng rice water used by the Red Yao for centuries. Viori works directly with the Red Yao to purchase their ancient rice, at a premium, to create a long-term, sustainable partnership. Viori works with the Red Yao directly to initiate projects to bring about economic prosperity, ecological harmony, cultural preservation, and community wellbeing for their tribe.

To learn more about Viori’s mission click here.

Share article on social media or email:

World Parkinson Coalition Announces Top 12 Videos in WPC 2023 Video Competition – Voting now begins for People’s Choice Award


World Parkinson Coalition®

World Parkinson Coalition®

I’m heartened to know that SLIM SHAKY’s message of living a meaningful life in the face of challenges like Parkinson’s will reach viewers across the world…

World Parkinson Coalition ® announces Top 12 Videos for the WPC 2023 Video Competition. These selected videos collectively capture what many with Parkinson’s feel every day as they live with this disease, enabling viewers to visually, intellectually, and emotionally walk in their shoes. Moreover, the 12 videos inspire, encourage, educate and reassures that one can live life to the fullest when living with Parkinson’s disease.

Voting for the People’s Choice Award, chosen from among the Top 12 Videos, is now open and closes on April 20, 2023. Individuals are encouraged to view the 12 videos and choose their favorite. One vote is permitted per person. Both the Grand Prize-winning video and the People’s Choice Award video will be announced and shown at the Opening Ceremony on Tuesday, July 4, 2023 in Barcelona.

“One of the main purposes of the World Parkinson Congress (WPC 2023) is to bring people together from all over the world to share similar experiences from their lives with Parkinson’s disease,” states Elizabeth (Eli) Pollard, executive director, World Parkinson Coalition. “Video is a great way to capture and share the power of science, hope, humor, and inspiration,” adds Pollard. “It’s also a great way to encourage discourse about a disease that is often misunderstood.”

Ten judges, each connected to Parkinson’s disease, whether a researcher, a movement disorders specialist, care partner, past winner, or a friend of someone who lives with the disease reviewed 50 entries from around the world and chose 12 finalists and Honorary mentions from the pool of participants.

Judges have already selected the Grand prize winner from these Top 12 Videos and now it’s time for the public to select the WPC 2023 People’s Choice Award at https://wpc2023.org/page/Top12-WPC2023. WPC 2023 announce and show these two winning videos at the WPC 2023 Opening Ceremonies at the International Barcelona Convention Center on July 4, 2023.

“I’m thrilled that SLIM SHAKY has been selected for the Top 12, and I’m so grateful for this opportunity to share the stories of Heather Kennedy and my mom! It’s a great honor to play a part in the incredibly important work that WPC does for people whose lives have been impacted by Parkinson’s disease. I’m heartened to know that SLIM SHAKY’s message of living a meaningful life in the face of challenges like Parkinson’s will reach viewers across the world, and I hope that the lyrics can inspire, energize, and get stuck in everyone’s heads.”

About the World Parkinson Coalition® and WPC 2023

The World Parkinson Coalition Inc. is a nonprofit organization that provides an international forum for learning about the latest scientific discoveries, medical practices, care partner initiatives and advocacy work related to Parkinson’s disease. The World Parkinson Coalition® launched the first Congress in 2006 to provide a space for the global Parkinson’s community of researchers, clinicians, health care professionals, people with Parkinson’s and their care partners to meet in person, network and to share advances in Parkinson’s research, improve understanding and promote advocacy worldwide, and to potentially shape future research, treatment and care.

From its modest beginning to nearly 17,000 delegates who have participated in the previous Congresses, the WPC 2023 is expected to attract about 4,000 delegates. To learn more about the 6th World Parkinson Congress, please visit: http://www.wpc2023.org/

###

Share article on social media or email:

Improved Pharma presenting and sponsoring at ACS Spring 2023 national meeting


News Image

We understand the importance of intellectual property for our clients, and we appreciate having the opportunity to present at this year’s meeting

Improved Pharma will be at the ACS Spring 2023 National Meeting to be held in Indianapolis March 26 – 30, 2023. There are two opportunities to interact with Improved Pharma at this event.

On Monday March 27th is the reception is for the Chemistry and Law Division of ACS, whose purpose is to advance the understanding and application of the intersection between chemistry and relevant statutory, regulatory, and judicial framework. Improved Pharma is pleased to be a sponsor for this event. The reception takes place from 6:00 – 8:00 PM in room 239 at the Indiana Convention Center and is open to all attendees of the national meeting.

On March 28th, Pamela Smith, Vice President and COO of Improved Pharma will be presenting “Microspectroscopy in art conservation and archaeology: Early applications from the MML” in the Science in Support of Technical Art History session. Her presentation takes place at 8:05 AM in room 122 at the Indiana Convention Center. Dr. Smith’s invited presentation opens the special session for the Division of the History of Chemistry. She will discuss how infrared, Raman, and visible microspectroscopy were used to identify pigments, dyes, binders, fibers, and other organic components in various paintings, fabrics, and manuscripts.

“We are pleased to be able to contribute to the ACS Spring 2023 National meeting, where thousands of chemistry professionals meet to share ideas and advance scientific and technical knowledge”, remarked Sally Byrn, CEO of Improved Pharma. “We understand the importance of intellectual property for our clients, and we appreciate having the opportunity to present at this year’s meeting.”

About Improved Pharma

Improved Pharma is a research, consulting, and information company dedicated to improving pharmaceutical methods, formulations, and processes. Services include solid-state form studies, formulation design, synchrotron techniques, analytical testing, and expert consulting for the development and defense of intellectual property matters. The company was founded in 2006 by Stephen and Sarah Byrn, who also founded SSCI.

For more information about Improved Pharma’s services, please contact us at 1-765-463-9951 or info@improvedpharma.com.

Share article on social media or email: